Jack Meehan
Stock Analyst at Barclays
(3.06)
# 1,349
Out of 5,055 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $266.89 | +8.66% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $146.82 | -14.86% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $379.40 | -24.09% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $11.38 | +189.98% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $120.67 | +169.33% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.17 | +34.09% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $186.95 | -47.04% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $162.29 | +10.91% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $6.72 | +48.92% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $220.61 | -24.75% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $74.15 | -42.01% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $167.81 | -8.23% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $313.15 | +37.31% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $314.40 | +36.77% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $21.34 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $41.62 | +15.33% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,403.08 | -51.54% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $80.70 | -62.83% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $578.71 | -48.16% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.36 | +2,841.18% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $266.89
Upside: +8.66%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $146.82
Upside: -14.86%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $379.40
Upside: -24.09%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $11.38
Upside: +189.98%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $120.67
Upside: +169.33%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.17
Upside: +34.09%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $186.95
Upside: -47.04%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $162.29
Upside: +10.91%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $6.72
Upside: +48.92%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $220.61
Upside: -24.75%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $74.15
Upside: -42.01%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $167.81
Upside: -8.23%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $313.15
Upside: +37.31%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $314.40
Upside: +36.77%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $21.34
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $41.62
Upside: +15.33%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,403.08
Upside: -51.54%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $80.70
Upside: -62.83%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $578.71
Upside: -48.16%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.36
Upside: +2,841.18%